Announcements

i&i Prague, the Technical University of Liberec, and the Faculty of Medicine of Charles University in Pilsen will support the technology for the prevention of complications in intestinal surgery

by
Jakob Ulrych
October 2, 2025
The i&i Prague biotechnology incubator, the Technical University of Liberec, and the Faculty of Medicine of Charles University in Pilsen have signed an incubation agreement to support the commercialization of the Nanoflexion project, an advanced medical nanotechnology aimed at reducing postoperative complications in gastrointestinal surgery. This agreement represents an important milestone in the journey of this technology from research to clinical practice.

The Nanoflexion technology, which was developed through interdisciplinary collaboration between material engineers and medical scientists, uses nanofiber materials to overcome long-standing problems in colorectal surgery. “Nanoflexion was born out of an urgent need to prevent serious post-surgical complications that have been troubling patients for decades. This agreement gives us the institutional backing and support we need to translate years of research into clinical reality,” said Markéta Hujerová (Klíčová), founder of the Nanoflexion project, who recently presented the project at the World Expo in Osaka, Japan.

The technology is based on the application of patches that use electrostatically spun nanofibers to create a tissue-friendly protective layer around the surgical site. The patch is applied directly during surgery, where it serves as a protective barrier on the intestinal anastomosis and helps prevent adhesions and leakage of intestinal contents. The project is currently in the preclinical development phase with the aim of initiating the first clinical trials.

 

Comprehensive innovation ecosystem

Under the signed agreement, i&i Prague will provide incubation support in the form of expert advice on scientific, legal, commercial, and other issues, while the Technical University of Liberec and the Faculty of Medicine in Pilsen will participate in research and preclinical verification of the technology.

“At i&i Prague, we focus on supporting breakthrough innovations that can fundamentally improve patient care. Nanoflexion fits perfectly into our vision of supporting scalable and beneficial technologies,” said Roberto Fernandez Alvarez, incubation manager at i&i Prague.

“The Technical University of Liberec is the cradle of industrial nanofiber production, thanks to the patented technology for producing nanofibers by electrostatic spinning – Nanospider®, which was introduced to the world in 2004 by the team of Professor Oldřich Jirsák from the Faculty of Textile Engineering at TUL. Over the past twenty years, researchers from our university have registered 170 patents, more than 20 of which are in the field of nanofiber production. Nanoflexion is another scientific and research success in the field of nanofibers, which was born in cooperation with other partners, primarily clinical doctors from the Faculty of Medicine at the University of Pilsen, in Liberec,” said Petr Lenfeld, Vice-Rector for Science and Research at the Technical University of Liberec.

“From the perspective of the medical faculty, we see great potential in Nanoflexion technology for reducing postoperative complications in colorectal surgery. We are happy to contribute our experience in its preclinical and future clinical testing,” added Prof. MUDr. Václav Liška, Ph.D., from the Faculty of Medicine at Charles University in Pilsen.

Subscribe to our newsletter

Join our newsletter to get the best hottest startup tapas.

Popular posts

London Quantum Group launches from stealth with $1.2M to solve one of healthcare AI’s biggest challenges

August 6, 2026

Estel Technologies Closes Pre-Seed Round to Fix the €60 Billion Problem Draining Tech Staffing Sales Every Year

August 4, 2026

Czech Pale Fire Capital Warns of Investment Scams Exploiting the Identity of their Partner Dušan Šenkypl

August 4, 2026

Related posts

Norwegian AI startup Visoid has raised $2.5 million in a seed round led by Skyfall Ventures, with participation from Farvatn Venture and byFounders Angel Collective, alongside existing investors StartupLab, OBOS, and Antler. The company previously raised €700,000 in 2025 from StartupLab, Antler, OBOS, and other investors.
by
Jakob Ulrych
Ukrainian-Swiss startup Caslog opens pre-seed round for front-line medical device.
by
Fergus O'Sullivan
Artificial intelligence is reshaping healthcare at an unprecedented pace, but one fundamental obstacle continues to slow progress: access to sensitive patient data.
by
Jakob Ulrych
The defence technology startup Monava has secured a new funding round to accelerate the commercial expansion of its AI-powered acoustic drone detection platform as demand for passive counter-drone solutions continues to surge across Europe.
by
Jakob Ulrych